Viewing Study NCT04676360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-03-07 @ 10:44 PM
Study NCT ID: NCT04676360
Status: TERMINATED
Last Update Posted: 2025-09-25
First Post: 2020-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma
Sponsor: Jacob Soumerai, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Plasmablastic Lymphoma View
None Refractory Plasmablastic Lymphoma View
None Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed Plasmablastic Lymphom View
None Refractory Plasmablastic Lymphoma View
None Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma View